National Institute for Health and Care Excellence3 天
Published guidance, NICE advice and quality standards
Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments TA1023 11 December 2024 11 December 2024 ...
National Institute for Health and Care Excellence16 天
In consultation: Guidance and quality standards
Health inequalities modular update to NICE health technology evaluations: the manual (PMG36) Methods / process manual consultation NICE process and methods 31 January 2025 Highly specialised ...
National Institute for Health and Care Excellence4 年
Drug misuse
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
National Institute for Health and Care Excellence9 年
Eye conditions
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
National Institute for Health and Care Excellence10 年
Breast cancer
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
National Institute for Health and Care Excellence2 个月
Measuring the use of NICE guidance
The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England which have been positively appraised by NICE.
National Institute for Health and Care Excellence4 年
Embolism and thrombosis
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
National Institute for Health and Care Excellence5 个月
In development: Guidance, quality standards and advice
12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280] Technology appraisal guidance 12 February 2025 Abaloparatide for treating ...
National Institute for Health and Care Excellence9 年
Older people
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
National Institute for Health and Care Excellence10 年
Diet, nutrition and obesity
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
National Institute for Health and Care Excellence4 年
COVID-19
All NICE products on COVID-19. Includes any guidance and advice.
National Institute for Health and Care Excellence2 个月
Chronic obstructive pulmonary disease
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.